ID   PDE6C_HUMAN             Reviewed;         858 AA.
AC   P51160; A6NCR6; Q5VY29;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   12-APR-2017, entry version 161.
DE   RecName: Full=Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha';
DE            EC=3.1.4.35;
DE   AltName: Full=cGMP phosphodiesterase 6C;
DE   Flags: Precursor;
GN   Name=PDE6C; Synonyms=PDEA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=8543163; DOI=10.1016/0378-1119(95)00585-4;
RA   Viczian A.S., Piriev N.I., Farber D.B.;
RT   "Isolation and characterization of a cDNA encoding the alpha' subunit
RT   of human cone cGMP-phosphodiesterase.";
RL   Gene 166:205-211(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Retina;
RX   PubMed=7490077; DOI=10.1006/geno.1995.1171;
RA   Piriev N.I., Viczian A.S., Ye J., Kerner B., Korenberg J.R.,
RA   Farber D.B.;
RT   "Gene structure and amino acid sequence of the human cone
RT   photoreceptor cGMP-phosphodiesterase alpha' subunit (PDEA2) and its
RT   chromosomal localization to 10q24.";
RL   Genomics 28:429-435(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT THR-270.
RC   TISSUE=Retina;
RX   PubMed=8641425; DOI=10.1016/0014-5793(96)00104-4;
RA   Feshchenko E.A., Andreeva S.G., Suslova V.A., Smirnova E.V.,
RA   Zagranichny V.E., Lipkin V.M.;
RT   "Human cone-specific cGMP phosphodiesterase alpha' subunit: complete
RT   cDNA sequence and gene arrangement.";
RL   FEBS Lett. 381:149-152(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   VARIANTS GLU-157; ASN-822 AND GLY-834.
RX   PubMed=10393054;
RA   Gao Y.Q., Danciger M., Longmuir R., Piriev N.I., Zhao D.Y.,
RA   Heckenlively J.R., Fishman G.A., Weleber R.G., Jacobson S.G.,
RA   Stone E.M., Farber D.B.;
RT   "Screening of the gene encoding the alpha'-subunit of cone cGMP-PDE in
RT   patients with retinal degenerations.";
RL   Invest. Ophthalmol. Vis. Sci. 40:1818-1822(1999).
RN   [7]
RP   VARIANTS COD4 TRP-29; ASN-323 AND VAL-455.
RX   PubMed=19615668; DOI=10.1016/j.ajhg.2009.06.016;
RA   Thiadens A.A., den Hollander A.I., Roosing S., Nabuurs S.B.,
RA   Zekveld-Vroon R.C., Collin R.W., De Baere E., Koenekoop R.K.,
RA   van Schooneveld M.J., Strom T.M., van Lith-Verhoeven J.J.,
RA   Lotery A.J., van Moll-Ramirez N., Leroy B.P., van den Born L.I.,
RA   Hoyng C.B., Cremers F.P., Klaver C.C.;
RT   "Homozygosity mapping reveals PDE6C mutations in patients with early-
RT   onset cone photoreceptor disorders.";
RL   Am. J. Hum. Genet. 85:240-247(2009).
RN   [8]
RP   VARIANT SER-826.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =
CC       guanosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000250};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000250};
CC   -!- SUBUNIT: Composed of two alpha' subunits that are associated with
CC       3 smaller proteins of 11, 13, and 15 kDa.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC   -!- DISEASE: Cone dystrophy 4 (COD4) [MIM:613093]: An early-onset cone
CC       dystrophy. Cone dystrophies are retinal dystrophies characterized
CC       by progressive degeneration of the cone photoreceptors with
CC       preservation of rod function, as indicated by electroretinogram.
CC       However, some rod involvement may be present in some cone
CC       dystrophies, particularly at late stage. Affected individuals
CC       suffer from photophobia, loss of visual acuity, color vision and
CC       central visual field. Another sign is the absence of macular
CC       lesions for many years. Cone dystrophies are distinguished from
CC       the cone-rod dystrophies in which some loss of peripheral vision
CC       also occurs. {ECO:0000269|PubMed:19615668}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U31973; AAA96392.1; -; mRNA.
DR   EMBL; U20212; AAA92886.1; -; Genomic_DNA.
DR   EMBL; U20196; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20197; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20199; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20200; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20201; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20202; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20203; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20204; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20205; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20206; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20207; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20208; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20209; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20210; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; U20211; AAA92886.1; JOINED; Genomic_DNA.
DR   EMBL; X94354; CAA64079.1; -; Genomic_DNA.
DR   EMBL; AL356214; CAH72330.1; -; Genomic_DNA.
DR   EMBL; AL157396; CAH72330.1; JOINED; Genomic_DNA.
DR   EMBL; AL157396; CAH73839.1; -; Genomic_DNA.
DR   EMBL; AL356214; CAH73839.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW50064.1; -; Genomic_DNA.
DR   CCDS; CCDS7429.1; -.
DR   PIR; S63688; JC4520.
DR   RefSeq; NP_006195.3; NM_006204.3.
DR   UniGene; Hs.658121; -.
DR   PDB; 3JWQ; X-ray; 2.87 A; A/B/C/D=746-785.
DR   PDB; 3JWR; X-ray; 2.99 A; A/B=746-785.
DR   PDB; 5E8F; X-ray; 2.10 A; D/E=851-855.
DR   PDBsum; 3JWQ; -.
DR   PDBsum; 3JWR; -.
DR   PDBsum; 5E8F; -.
DR   ProteinModelPortal; P51160; -.
DR   SMR; P51160; -.
DR   STRING; 9606.ENSP00000360502; -.
DR   BindingDB; P51160; -.
DR   ChEMBL; CHEMBL3977; -.
DR   DrugBank; DB00201; Caffeine.
DR   GuidetoPHARMACOLOGY; 1314; -.
DR   iPTMnet; P51160; -.
DR   PhosphoSitePlus; P51160; -.
DR   BioMuta; PDE6C; -.
DR   DMDM; 90111861; -.
DR   EPD; P51160; -.
DR   PaxDb; P51160; -.
DR   PeptideAtlas; P51160; -.
DR   PRIDE; P51160; -.
DR   DNASU; 5146; -.
DR   Ensembl; ENST00000371447; ENSP00000360502; ENSG00000095464.
DR   GeneID; 5146; -.
DR   KEGG; hsa:5146; -.
DR   UCSC; uc001kiu.5; human.
DR   CTD; 5146; -.
DR   DisGeNET; 5146; -.
DR   GeneCards; PDE6C; -.
DR   GeneReviews; PDE6C; -.
DR   H-InvDB; HIX0035433; -.
DR   HGNC; HGNC:8787; PDE6C.
DR   MalaCards; PDE6C; -.
DR   MIM; 600827; gene.
DR   MIM; 613093; phenotype.
DR   neXtProt; NX_P51160; -.
DR   OpenTargets; ENSG00000095464; -.
DR   Orphanet; 49382; Achromatopsia.
DR   Orphanet; 1871; Progressive cone dystrophy.
DR   PharmGKB; PA33135; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   eggNOG; ENOG410XRI7; LUCA.
DR   GeneTree; ENSGT00760000119066; -.
DR   HOGENOM; HOG000007069; -.
DR   HOVERGEN; HBG053539; -.
DR   KO; K13757; -.
DR   OMA; IVMGKEV; -.
DR   OrthoDB; EOG091G01RK; -.
DR   PhylomeDB; P51160; -.
DR   TreeFam; TF316499; -.
DR   GeneWiki; PDE6C; -.
DR   GenomeRNAi; 5146; -.
DR   PRO; PR:P51160; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000095464; -.
DR   CleanEx; HS_PDE6C; -.
DR   Genevisible; P51160; HS.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007603; P:phototransduction, visible light; IEA:Ensembl.
DR   GO; GO:0046549; P:retinal cone cell development; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF_dom-like.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; SSF55781; 3.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; cGMP; cGMP-binding; Complete proteome;
KW   Disease mutation; Hydrolase; Lipoprotein; Membrane; Metal-binding;
KW   Methylation; Nucleotide-binding; Polymorphism; Prenylation;
KW   Reference proteome; Repeat; Sensory transduction; Vision.
FT   CHAIN         1    855       Cone cGMP-specific 3',5'-cyclic
FT                                phosphodiesterase subunit alpha'.
FT                                /FTId=PRO_0000198831.
FT   PROPEP      856    858       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000370788.
FT   DOMAIN       75    224       GAF 1.
FT   DOMAIN      256    433       GAF 2.
FT   NP_BIND     169    172       cGMP. {ECO:0000250}.
FT   ACT_SITE    562    562       Proton donor. {ECO:0000250}.
FT   METAL       566    566       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       602    602       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       603    603       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       603    603       Divalent metal cation 2. {ECO:0000250}.
FT   METAL       723    723       Divalent metal cation 1. {ECO:0000250}.
FT   BINDING      97     97       cGMP. {ECO:0000250}.
FT   BINDING     116    116       cGMP. {ECO:0000250}.
FT   BINDING     176    176       cGMP. {ECO:0000250}.
FT   MOD_RES     855    855       Cysteine methyl ester. {ECO:0000255}.
FT   LIPID       855    855       S-geranylgeranyl cysteine. {ECO:0000250}.
FT   VARIANT      29     29       R -> W (in COD4; dbSNP:rs121918537).
FT                                {ECO:0000269|PubMed:19615668}.
FT                                /FTId=VAR_062408.
FT   VARIANT     157    157       D -> E (rare polymorphism;
FT                                dbSNP:rs76999928).
FT                                {ECO:0000269|PubMed:10393054}.
FT                                /FTId=VAR_025470.
FT   VARIANT     270    270       S -> T (in dbSNP:rs701865).
FT                                {ECO:0000269|PubMed:8641425}.
FT                                /FTId=VAR_050475.
FT   VARIANT     323    323       Y -> N (in COD4; dbSNP:rs121918538).
FT                                {ECO:0000269|PubMed:19615668}.
FT                                /FTId=VAR_062409.
FT   VARIANT     455    455       M -> V (in COD4; dbSNP:rs121918539).
FT                                {ECO:0000269|PubMed:19615668}.
FT                                /FTId=VAR_062410.
FT   VARIANT     699    699       E -> A (in dbSNP:rs12261131).
FT                                /FTId=VAR_050476.
FT   VARIANT     822    822       K -> N (rare polymorphism;
FT                                dbSNP:rs79487435).
FT                                {ECO:0000269|PubMed:10393054}.
FT                                /FTId=VAR_025471.
FT   VARIANT     826    826       I -> S (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064744.
FT   VARIANT     834    834       E -> G (rare polymorphism;
FT                                dbSNP:rs148661165).
FT                                {ECO:0000269|PubMed:10393054}.
FT                                /FTId=VAR_025472.
FT   CONFLICT    116    116       D -> V (in Ref. 1; AAA96392 and 2;
FT                                AAA92886). {ECO:0000305}.
FT   CONFLICT    373    373       Q -> P (in Ref. 1; AAA96392).
FT                                {ECO:0000305}.
FT   CONFLICT    464    464       P -> L (in Ref. 1; AAA96392).
FT                                {ECO:0000305}.
FT   CONFLICT    565    565       R -> Q (in Ref. 1; AAA96392 and 2;
FT                                AAA92886). {ECO:0000305}.
FT   HELIX       746    754       {ECO:0000244|PDB:3JWQ}.
FT   HELIX       762    764       {ECO:0000244|PDB:3JWQ}.
FT   HELIX       766    771       {ECO:0000244|PDB:3JWQ}.
FT   HELIX       772    782       {ECO:0000244|PDB:3JWQ}.
SQ   SEQUENCE   858 AA;  99147 MW;  06FFD025EE5936A5 CRC64;
     MGEINQVAVE KYLEENPQFA KEYFDRKLRV EVLGEIFKNS QVPVQSSMSF SELTQVEESA
     LCLELLWTVQ EEGGTPEQGV HRALQRLAHL LQADRCSMFL CRSRNGIPEV ASRLLDVTPT
     SKFEDNLVGP DKEVVFPLDI GIVGWAAHTK KTHNVPDVKK NSHFSDFMDK QTGYVTKNLL
     ATPIVVGKEV LAVIMAVNKV NASEFSKQDE EVFSKYLNFV SIILRLHHTS YMYNIESRRS
     QILMWSANKV FEELTDVERQ FHKALYTVRS YLNCERYSIG LLDMTKEKEF YDEWPIKLGE
     VEPYKGPKTP DGREVNFYKI IDYILHGKEE IKVIPTPPAD HWTLISGLPT YVAENGFICN
     MMNAPADEYF TFQKGPVDET GWVIKNVLSL PIVNKKEDIV GVATFYNRKD GKPFDEHDEY
     ITETLTQFLG WSLLNTDTYD KMNKLENRKD IAQEMLMNQT KATPEEIKSI LKFQEKLNVD
     VIDDCEEKQL VAILKEDLPD PRSAELYEFR FSDFPLTEHG LIKCGIRLFF EINVVEKFKV
     PVEVLTRWMY TVRKGYRAVT YHNWRHGFNV GQTMFTLLMT GRLKKYYTDL EAFAMLAAAF
     CHDIDHRGTN NLYQMKSTSP LARLHGSSIL ERHHLEYSKT LLQDESLNIF QNLNKRQFET
     VIHLFEVAII ATDLALYFKK RTMFQKIVDA CEQMQTEEEA IKYVTVDPTK KEIIMAMMMT
     ACDLSAITKP WEVQSQVALM VANEFWEQGD LERTVLQQQP IPMMDRNKRD ELPKLQVGFI
     DFVCTFVYKE FSRFHKEITP MLSGLQNNRV EWKSLADEYD AKMKVIEEEA KKQEGGAEKA
     AEDSGGGDDK KSKTCLML
//
